Want to see ANTX full AI Analyst Report?
AN2 Therapeutics, Inc. (ANTX) Ownership Overview
14.95% Insiders
3.41% Mutual Funds
38.38% Other Institutional Investors
7.01% ETFs
36.24% Public Companies and
Individual Investors
The ownership structure of AN2 Therapeutics, Inc. (ANTX) stock is a mix of institutional, retail, and individual investors. Approximately 48.81% of the company’s stock is owned by Institutional Investors, 14.95% is owned by Insiders, and 36.24% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Sep 04, 2026 | xxxxxxxxxxxxx | $1504 | |
Sep 02, 2026 | xxxxxxxxxxxxx | $11602 | |
Jun 02, 2026 | xxxxxxxxxxxxx | $1174 | |
Mar 05, 2026 | xxxxxxxxxxxxx | $347 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $2225456 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,435,071 | Insider | 6.45% | 9,399,374 | |
| 1,628,512 | Insider | 4.32% | 6,286,056 | |
| 1,394,177 | Institution | 3.69% | 5,381,523 | |
| 985,504 | Institution | 2.61% | 3,804,045 | |
| 981,798 | Institution | 2.60% | 3,789,740 | |
| 633,842 | Insider | 1.68% | 2,446,630 | |
| 459,805 | Institution | 1.22% | 1,774,847 | |
| 207,543 | Institution | 0.55% | 801,116 | |
| 206,554 | Insider | 0.55% | 797,298 | |
| 145,538 | Insider | 0.39% | 561,777 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 985,504 | Institution | 2.61% | 3,804,045 | |
| 207,543 | Institution | 0.55% | 801,116 | |
| 59,000 | Institution | 0.16% | 227,740 | |
| 12,793 | Institution | 0.03% | 49,381 | |
| 12,781 | Institution | 0.03% | 49,335 | |
| 8,508 | Institution | 0.02% | 32,841 | |
| 1,347 | Institution | <0.01% | 5,199 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 853,017 | Institution | 2.26% | 4,538,050 | |
| 650,484 | Institution | 1.72% | 2,510,868 | |
| 360,114 | Institution | 0.95% | 1,915,806 | |
| 221,326 | Institution | 0.59% | 854,318 | |
| 153,165 | Institution | 0.41% | 814,838 | |
| 80,758 | Institution | 0.21% | 311,726 | |
| 57,605 | Institution | 0.15% | 209,106 | |
| 41,487 | Institution | 0.11% | 232,742 | |
| 40,928 | Institution | 0.11% | 157,982 | |
| 35,133 | Institution | 0.09% | 127,533 |
FAQ
Who Owns AN2 Therapeutics, Inc. (ANTX)?
According to the latest TipRanks data, approximately 38.38% of the company's stock is held by institutional investors, 14.95% is held by insiders, and 36.24% is held by retail investors.
What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 38.38% of AN2 Therapeutics, Inc. (ANTX) stock is held by institutional investors.
What percentage of AN2 Therapeutics, Inc. (ANTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 36.24% of AN2 Therapeutics, Inc. (ANTX) stock is held by retail investors.
Who owns the most shares of AN2 Therapeutics, Inc. (ANTX)?
Kabeer Aziz owns the most shares of AN2 Therapeutics, Inc. (ANTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.